Silverlake Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-633
| Closed | -$392K | – | 285 |
|
|
2024
Q3 | $392K | Sell |
633
-34
| -5% | -$21K | 0.15% | 166 |
|
|
2024
Q2 | $369K | Sell |
667
-4
| -0.6% | -$2.21K | 0.15% | 167 |
|
|
2024
Q1 | $390K | Sell |
671
-3
| -0.4% | -$1.74K | 0.2% | 137 |
|
|
2023
Q4 | $358K | Sell |
674
-18
| -3% | -$9.56K | 0.2% | 137 |
|
|
2023
Q3 | $350K | Buy |
692
+4
| +0.6% | +$2.03K | 0.2% | 143 |
|
|
2023
Q2 | $359K | Sell |
688
-23
| -3% | -$12K | 0.2% | 134 |
|
|
2023
Q1 | $410K | Sell |
711
-5
| -0.7% | -$2.88K | 0.25% | 108 |
|
|
2022
Q4 | $394K | Buy |
716
+31
| +5% | +$17.1K | 0.25% | 105 |
|
|
2022
Q3 | $347K | Buy |
685
+17
| +3% | +$8.62K | 0.24% | 112 |
|
|
2022
Q2 | $363K | Buy |
668
+2
| +0.3% | +$1.09K | 0.24% | 110 |
|
|
2022
Q1 | $393K | Sell |
666
-2
| -0.3% | -$1.18K | 0.22% | 125 |
|
|
2021
Q4 | $446K | Buy |
+668
| New | +$446K | 0.24% | 106 |
|